COVID-19 and Cushing's syndrome: recommendations for a special population with endogenous glucocorticoid excess

Affiliations

• ¹ Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Università Federico II di Napoli, Naples 80131, Italy; UNESCO Chair for Health Education and Sustainable Development, Federico II University, Naples, Italy. Electronic address: rosario.pivonello@unina.it.
• ² Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Università Federico II di Napoli, Naples 80131, Italy.
• ³ Department of Experimental Medicine, Sapienza University of Rome - Policlinico Umberto I - COVID Hospital, Rome, Italy.
• ⁴ Neuroendocrine and Pituitary Tumor Clinical Center, Massachusetts General Hospital, Boston, MA, USA.
• ⁵ Centre for Endocrinology, Barts and the London School of Medicine, Queen Mary University of London, London, UK; Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK.
• ⁶ Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Università Federico II di Napoli, Naples 80131, Italy; UNESCO Chair for Health Education and Sustainable Development, Federico II University, Naples, Italy.